{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T16:29:07Z","timestamp":1792772947273,"version":"4.5.0"},"reference-count":107,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T00:00:00Z","timestamp":1790294400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T00:00:00Z","timestamp":1790294400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Cancer"],"DOI":"10.1038\/s43018-026-01242-y","type":"journal-article","created":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T09:02:50Z","timestamp":1790326970000},"page":"1482-1493","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Unraveling the lexicon of complex mutational phenomena in human cancers"],"prefix":"10.1038","volume":"7","author":[{"given":"Ting","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik N.","family":"Bergstrom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0285-0549","authenticated-orcid":false,"given":"Stanley","family":"Clarke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcin","family":"Imieli\u0144ski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3596-4515","authenticated-orcid":false,"given":"Ludmil B.","family":"Alexandrov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,25]]},"reference":[{"key":"1242_CR1","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1038\/nature07943","volume":"458","author":"MR Stratton","year":"2009","unstructured":"Stratton, M. R., Campbell, P. J. & Futreal, P. A. The cancer genome. Nature 458, 719\u2013724 (2009).","journal-title":"Nature"},{"key":"1242_CR2","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1038\/nature08658","volume":"463","author":"ED Pleasance","year":"2010","unstructured":"Pleasance, E. D. et al. A comprehensive catalogue of somatic mutations from a human cancer genome. Nature 463, 191\u2013196 (2010).","journal-title":"Nature"},{"key":"1242_CR3","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1016\/j.cell.2017.07.003","volume":"170","author":"F Supek","year":"2017","unstructured":"Supek, F. & Lehner, B. Clustered mutation signatures reveal that error-prone DNA repair targets mutations to active genes. Cell 170, 534\u2013547 (2017).","journal-title":"Cell"},{"key":"1242_CR4","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1016\/j.molcel.2012.03.030","volume":"46","author":"SA Roberts","year":"2012","unstructured":"Roberts, S. A. et al. Clustered mutations in yeast and in human cancers can arise from damaged long single-strand DNA regions. Mol. Cell 46, 424\u2013435 (2012).","journal-title":"Mol. Cell"},{"key":"1242_CR5","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1080\/15384101.2017.1404208","volume":"17","author":"IB Rogozin","year":"2018","unstructured":"Rogozin, I. B. et al. DNA polymerase \u03b7 mutational signatures are found in a variety of different types of cancer. Cell Cycle 17, 348\u2013355 (2018).","journal-title":"Cell Cycle"},{"key":"1242_CR6","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1038\/s41586-020-1943-3","volume":"578","author":"LB Alexandrov","year":"2020","unstructured":"Alexandrov, L. B. et al. The repertoire of mutational signatures in human cancer. Nature 578, 94\u2013101 (2020).","journal-title":"Nature"},{"key":"1242_CR7","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1016\/j.cell.2012.04.024","volume":"149","author":"S Nik-Zainal","year":"2012","unstructured":"Nik-Zainal, S. et al. Mutational processes molding the genomes of 21 breast cancers. Cell 149, 979\u2013993 (2012).","journal-title":"Cell"},{"key":"1242_CR8","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1038\/s41588-020-0674-6","volume":"52","author":"D Mas-Ponte","year":"2020","unstructured":"Mas-Ponte, D. & Supek, F. DNA mismatch repair promotes APOBEC3-mediated diffuse hypermutation in human cancers. Nat. Genet. 52, 958\u2013968 (2020).","journal-title":"Nat. Genet."},{"key":"1242_CR9","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1038\/s41586-022-04398-6","volume":"602","author":"EN Bergstrom","year":"2022","unstructured":"Bergstrom, E. N. et al. Mapping clustered mutations in cancer reveals APOBEC3 mutagenesis of ecDNA. Nature 602, 510\u2013517 (2022).","journal-title":"Nature"},{"key":"1242_CR10","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.cell.2010.11.055","volume":"144","author":"PJ Stephens","year":"2011","unstructured":"Stephens, P. J. et al. Massive genomic rearrangement acquired in a single catastrophic event during cancer development. Cell 144, 27\u201340 (2011).","journal-title":"Cell"},{"key":"1242_CR11","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1016\/j.cell.2013.03.021","volume":"153","author":"SC Baca","year":"2013","unstructured":"Baca, S. C. et al. Punctuated evolution of prostate cancer genomes. Cell 153, 666\u2013677 (2013).","journal-title":"Cell"},{"key":"1242_CR12","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1016\/j.ccr.2013.04.025","volume":"23","author":"MM Shen","year":"2013","unstructured":"Shen, M. M. Chromoplexy: a new category of complex rearrangements in the cancer genome. Cancer Cell 23, 567\u2013569 (2013).","journal-title":"Cancer Cell"},{"key":"1242_CR13","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.cell.2020.08.006","volume":"183","author":"K Hadi","year":"2020","unstructured":"Hadi, K. et al. Distinct classes of complex structural variation uncovered across thousands of cancer genome graphs. Cell 183, 197\u2013210 (2020).","journal-title":"Cell"},{"key":"1242_CR14","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1016\/j.cell.2011.07.042","volume":"146","author":"P Liu","year":"2011","unstructured":"Liu, P. et al. Chromosome catastrophes involve replication mechanisms generating complex genomic rearrangements. Cell 146, 889\u2013903 (2011).","journal-title":"Cell"},{"key":"1242_CR15","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.1038\/nm.2988","volume":"18","author":"AJ Holland","year":"2012","unstructured":"Holland, A. J. & Cleveland, D. W. Chromoanagenesis and cancer: mechanisms and consequences of localized, complex chromosomal rearrangements. Nat. Med. 18, 1630\u20131638 (2012).","journal-title":"Nat. Med."},{"key":"1242_CR16","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.semcdb.2021.01.004","volume":"123","author":"F Pellestor","year":"2022","unstructured":"Pellestor, F., Gaillard, J. B., Schneider, A., Puechberty, J. & Gatinois, V. Chromoanagenesis, the mechanisms of a genomic chaos. Semin. Cell Dev. Biol. 123, 90\u201399 (2022).","journal-title":"Semin. Cell Dev. Biol."},{"key":"1242_CR17","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s13039-020-0470-0","volume":"13","author":"F Pellestor","year":"2020","unstructured":"Pellestor, F. & Gatinois, V. Chromoanagenesis: a piece of the macroevolution scenario. Mol. Cytogenet. 13, 3 (2020).","journal-title":"Mol. Cytogenet."},{"key":"1242_CR18","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1016\/j.cell.2024.12.005","volume":"188","author":"J Espejo Valle-Inclan","year":"2025","unstructured":"Espejo Valle-Inclan, J. et al. Ongoing chromothripsis underpins osteosarcoma genome complexity and clonal evolution. Cell 188, 352\u2013370 (2025).","journal-title":"Cell"},{"key":"1242_CR19","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1038\/s41586-023-06057-w","volume":"618","author":"JJ Lee","year":"2023","unstructured":"Lee, J. J. et al. ER\u03b1-associated translocations underlie oncogene amplifications in breast cancer. Nature 618, 1024\u20131032 (2023).","journal-title":"Nature"},{"key":"1242_CR20","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1073\/pnas.28.11.458","volume":"28","author":"B McClintock","year":"1942","unstructured":"McClintock, B. The fusion of broken ends of chromosomes following nuclear fusion. Proc. Natl Acad. Sci. USA 28, 458\u2013463 (1942).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1242_CR21","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1016\/j.celrep.2016.06.026","volume":"16","author":"M D\u2019Antonio","year":"2016","unstructured":"D\u2019Antonio, M., Tamayo, P., Mesirov, J. P. & Frazer, K. A. Kataegis expression signature in breast cancer is associated with late onset, better prognosis, and higher HER2 levels. Cell Rep. 16, 672\u2013683 (2016).","journal-title":"Cell Rep."},{"key":"1242_CR22","doi-asserted-by":"publisher","first-page":"3470","DOI":"10.1093\/bioinformatics\/btac335","volume":"38","author":"EN Bergstrom","year":"2022","unstructured":"Bergstrom, E. N., Kundu, M., Tbeileh, N. & Alexandrov, L. B. Examining clustered somatic mutations with SigProfilerClusters. Bioinformatics 38, 3470\u20133473 (2022).","journal-title":"Bioinformatics"},{"key":"1242_CR23","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1016\/j.cell.2019.02.012","volume":"176","author":"M Petljak","year":"2019","unstructured":"Petljak, M. et al. Characterizing mutational signatures in human cancer cell lines reveals episodic APOBEC mutagenesis. Cell 176, 1282\u20131294 (2019).","journal-title":"Cell"},{"key":"1242_CR24","doi-asserted-by":"publisher","unstructured":"Law, E. K. et al. APOBEC3A catalyzes mutation and drives carcinogenesis in vivo. J. Exp. Med. 217, e20200261 https:\/\/doi.org\/10.1084\/jem.20200261 (2020).","DOI":"10.1084\/jem.20200261"},{"key":"1242_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.dnarep.2020.102905","volume":"94","author":"M Petljak","year":"2020","unstructured":"Petljak, M. & Maciejowski, J. Molecular origins of APOBEC-associated mutations in cancer. DNA Repair 94, 102905 (2020).","journal-title":"DNA Repair"},{"key":"1242_CR26","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.dnarep.2016.05.029","volume":"43","author":"P Pham","year":"2016","unstructured":"Pham, P. et al. Structural analysis of the activation-induced deoxycytidine deaminase required in immunoglobulin diversification. DNA Repair 43, 48\u201356 (2016).","journal-title":"DNA Repair"},{"key":"1242_CR27","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1038\/nri.2016.2","volume":"16","author":"R Casellas","year":"2016","unstructured":"Casellas, R. et al. Mutations, kataegis and translocations in B cells: understanding AID promiscuous activity. Nat. Rev. Immunol. 16, 164\u2013176 (2016).","journal-title":"Nat. Rev. Immunol."},{"key":"1242_CR28","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1158\/2159-8290.CD-15-0344","volume":"5","author":"C Swanton","year":"2015","unstructured":"Swanton, C., McGranahan, N., Starrett, G. J. & Harris, R. S. APOBEC enzymes: mutagenic fuel for cancer evolution and heterogeneity. Cancer Discov. 5, 704\u2013712 (2015).","journal-title":"Cancer Discov."},{"key":"1242_CR29","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.965312","volume":"13","author":"E Cakan","year":"2022","unstructured":"Cakan, E. & Gunaydin, G. Activation induced cytidine deaminase: an old friend with new faces. Front. Immunol. 13, 965312 (2022).","journal-title":"Front. Immunol."},{"key":"1242_CR30","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms7997","volume":"6","author":"BA Walker","year":"2015","unstructured":"Walker, B. A. et al. APOBEC family mutational signatures are associated with poor prognosis translocations in multiple myeloma. Nat. Commun. 6, 6997 (2015).","journal-title":"Nat. Commun."},{"key":"1242_CR31","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1038\/s41586-023-06303-1","volume":"620","author":"H Isozaki","year":"2023","unstructured":"Isozaki, H. et al. Therapy-induced APOBEC3A drives evolution of persistent cancer cells. Nature 620, 393\u2013401 (2023).","journal-title":"Nature"},{"key":"1242_CR32","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1038\/s41588-025-02187-1","volume":"57","author":"A Gupta","year":"2025","unstructured":"Gupta, A. et al. APOBEC3 mutagenesis drives therapy resistance in breast cancer. Nat. Genet. 57, 1452\u20131462 (2025).","journal-title":"Nat. Genet."},{"key":"1242_CR33","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.00534","volume":"2","author":"BJ Taylor","year":"2013","unstructured":"Taylor, B. J. et al. DNA deaminases induce break-associated mutation showers with implication of APOBEC3B and 3A in breast cancer kataegis. eLife 2, e00534 (2013).","journal-title":"eLife"},{"key":"1242_CR34","doi-asserted-by":"publisher","first-page":"1640","DOI":"10.1016\/j.celrep.2014.04.053","volume":"7","author":"CJ Sakofsky","year":"2014","unstructured":"Sakofsky, C. J. et al. Break-induced replication is a source of mutation clusters underlying kataegis. Cell Rep. 7, 1640\u20131648 (2014).","journal-title":"Cell Rep."},{"key":"1242_CR35","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1038\/nature12585","volume":"502","author":"MA Wilson","year":"2013","unstructured":"Wilson, M. A. et al. PIF1 helicase and Pol\u03b4 promote recombination-coupled DNA synthesis via bubble migration. Nature 502, 393\u2013396 (2013).","journal-title":"Nature"},{"key":"1242_CR36","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1038\/nature12584","volume":"502","author":"N Saini","year":"2013","unstructured":"Saini, N. et al. Migrating bubble during break-induced replication drives conservative DNA synthesis. Nature 502, 389\u2013392 (2013).","journal-title":"Nature"},{"key":"1242_CR37","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.1016\/j.cell.2015.11.054","volume":"163","author":"J Maciejowski","year":"2015","unstructured":"Maciejowski, J., Li, Y., Bosco, N., Campbell, P. J. & de Lange, T. Chromothripsis and kataegis induced by telomere crisis. Cell 163, 1641\u20131654 (2015).","journal-title":"Cell"},{"key":"1242_CR38","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1038\/s41588-020-0667-5","volume":"52","author":"J Maciejowski","year":"2020","unstructured":"Maciejowski, J. et al. APOBEC3-dependent kataegis and TREX1-driven chromothripsis during telomere crisis. Nat. Genet. 52, 884\u2013890 (2020).","journal-title":"Nat. Genet."},{"key":"1242_CR39","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.03553","volume":"3","author":"BJ Taylor","year":"2014","unstructured":"Taylor, B. J., Wu, Y. L. & Rada, C. Active RNAP pre-initiation sites are highly mutated by cytidine deaminases in yeast, with AID targeting small RNA genes. eLife 3, e03553 (2014).","journal-title":"eLife"},{"key":"1242_CR40","doi-asserted-by":"publisher","first-page":"e1005217","DOI":"10.1371\/journal.pgen.1005217","volume":"11","author":"AG Lada","year":"2015","unstructured":"Lada, A. G. et al. Disruption of transcriptional coactivator SUB1 leads to genome-wide re-distribution of clustered mutations induced by APOBEC in active yeast genes. PLoS Genet. 11, e1005217 (2015).","journal-title":"PLoS Genet."},{"key":"1242_CR41","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.1038\/s41588-023-01504-w","volume":"55","author":"JL McCann","year":"2023","unstructured":"McCann, J. L. et al. APOBEC3B regulates R-loops and promotes transcription-associated mutagenesis in cancer. Nat. Genet. 55, 1721\u20131734 (2023).","journal-title":"Nat. Genet."},{"key":"1242_CR42","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1038\/s41586-022-04972-y","volume":"607","author":"M Petljak","year":"2022","unstructured":"Petljak, M. et al. Mechanisms of APOBEC3 mutagenesis in human cancer cells. Nature 607, 799\u2013807 (2022).","journal-title":"Nature"},{"key":"1242_CR43","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1016\/j.dnarep.2004.05.015","volume":"3","author":"PT Tran","year":"2004","unstructured":"Tran, P. T., Erdeniz, N., Symington, L. S. & Liskay, R. M. EXO1-A multi-tasking eukaryotic nuclease. DNA Repair 3, 1549\u20131559 (2004).","journal-title":"DNA Repair"},{"key":"1242_CR44","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1038\/nrm1907","volume":"7","author":"J Jiricny","year":"2006","unstructured":"Jiricny, J. The multifaceted mismatch-repair system. Nat. Rev. Mol. Cell Biol. 7, 335\u2013346 (2006).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"1242_CR45","doi-asserted-by":"publisher","first-page":"7096","DOI":"10.1093\/nar\/gkm750","volume":"35","author":"Y Iwatani","year":"2007","unstructured":"Iwatani, Y. et al. Deaminase-independent inhibition of HIV-1 reverse transcription by APOBEC3G. Nucleic Acids Res. 35, 7096\u20137108 (2007).","journal-title":"Nucleic Acids Res."},{"key":"1242_CR46","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1016\/j.celrep.2016.01.021","volume":"14","author":"JI Hoopes","year":"2016","unstructured":"Hoopes, J. I. et al. APOBEC3A and APOBEC3B preferentially deaminate the lagging strand template during DNA replication. Cell Rep. 14, 1273\u20131282 (2016).","journal-title":"Cell Rep."},{"key":"1242_CR47","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1038\/ng.2702","volume":"45","author":"SA Roberts","year":"2013","unstructured":"Roberts, S. A. et al. An APOBEC cytidine deaminase mutagenesis pattern is widespread in human cancers. Nat. Genet. 45, 970\u2013976 (2013).","journal-title":"Nat. Genet."},{"key":"1242_CR48","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2022.110555","volume":"38","author":"RA DeWeerd","year":"2022","unstructured":"DeWeerd, R. A. et al. Prospectively defined patterns of APOBEC3A mutagenesis are prevalent in human cancers. Cell Rep. 38, 110555 (2022).","journal-title":"Cell Rep."},{"key":"1242_CR49","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s13045-023-01425-5","volume":"16","author":"K Butler","year":"2023","unstructured":"Butler, K. & Banday, A. R. APOBEC3-mediated mutagenesis in cancer: causes, clinical significance and therapeutic potential. J. Hematol. Oncol. 16, 31 (2023).","journal-title":"J. Hematol. Oncol."},{"key":"1242_CR50","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.1021\/acsptsci.1c00091","volume":"4","author":"JJ King","year":"2021","unstructured":"King, J. J. et al. Structure-based design of first-generation small molecule inhibitors targeting the catalytic pockets of AID, APOBEC3A, and APOBEC3B. ACS Pharmacol. Transl. Sci. 4, 1390\u20131407 (2021).","journal-title":"ACS Pharmacol. Transl. Sci."},{"key":"1242_CR51","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1021\/acs.biochem.8b00858","volume":"58","author":"MV Kvach","year":"2019","unstructured":"Kvach, M. V. et al. Inhibiting APOBEC3 activity with single-stranded DNA containing 2\u2032-deoxyzebularine analogues. Biochemistry 58, 391\u2013400 (2019).","journal-title":"Biochemistry"},{"key":"1242_CR52","doi-asserted-by":"publisher","first-page":"e3001176","DOI":"10.1371\/journal.pbio.3001176","volume":"19","author":"J Biayna","year":"2021","unstructured":"Biayna, J. et al. Loss of the abasic site sensor HMCES is synthetic lethal with the activity of the APOBEC3A cytosine deaminase in cancer cells. PLoS Biol. 19, e3001176 (2021).","journal-title":"PLoS Biol."},{"key":"1242_CR53","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2020.107705","volume":"31","author":"KPM Mehta","year":"2020","unstructured":"Mehta, K. P. M., Lovejoy, C. A., Zhao, R., Heintzman, D. R. & Cortez, D. HMCES maintains replication fork progression and prevents double-strand breaks in response to APOBEC deamination and abasic site formation. Cell Rep. 31, 107705 (2020).","journal-title":"Cell Rep."},{"key":"1242_CR54","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1038\/nature21356","volume":"543","author":"KM Turner","year":"2017","unstructured":"Turner, K. M. et al. Extrachromosomal oncogene amplification drives tumour evolution and genetic heterogeneity. Nature 543, 122\u2013125 (2017).","journal-title":"Nature"},{"key":"1242_CR55","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1146\/annurev-pathmechdis-051821-114223","volume":"17","author":"S Wu","year":"2022","unstructured":"Wu, S., Bafna, V., Chang, H. Y. & Mischel, P. S. Extrachromosomal DNA: an emerging hallmark in human cancer. Annu. Rev. Pathol. 17, 367\u2013386 (2022).","journal-title":"Annu. Rev. Pathol."},{"key":"1242_CR56","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1038\/s41586-020-03064-z","volume":"591","author":"O Shoshani","year":"2021","unstructured":"Shoshani, O. et al. Chromothripsis drives the evolution of gene amplification in cancer. Nature 591, 137\u2013141 (2021).","journal-title":"Nature"},{"key":"1242_CR57","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1158\/2159-8290.CD-20-0936","volume":"12","author":"K Song","year":"2022","unstructured":"Song, K. et al. Plasticity of extrachromosomal and intrachromosomal BRAF amplifications in overcoming targeted therapy dosage challenges. Cancer Discov. 12, 1046\u20131069 (2022).","journal-title":"Cancer Discov."},{"key":"1242_CR58","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1038\/s41588-020-0678-2","volume":"52","author":"H Kim","year":"2020","unstructured":"Kim, H. et al. Extrachromosomal DNA is associated with oncogene amplification and poor outcome across multiple cancers. Nat. Genet. 52, 891\u2013897 (2020).","journal-title":"Nat. Genet."},{"key":"1242_CR59","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1038\/s41586-021-04116-8","volume":"600","author":"KL Hung","year":"2021","unstructured":"Hung, K. L. et al. ecDNA hubs drive cooperative intermolecular oncogene expression. Nature 600, 731\u2013736 (2021).","journal-title":"Nature"},{"key":"1242_CR60","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1038\/s41588-021-01000-z","volume":"54","author":"E van Leen","year":"2022","unstructured":"van Leen, E., Bruckner, L. & Henssen, A. G. The genomic and spatial mobility of extrachromosomal DNA and its implications for cancer therapy. Nat. Genet. 54, 107\u2013114 (2022).","journal-title":"Nat. Genet."},{"key":"1242_CR61","doi-asserted-by":"publisher","first-page":"1895","DOI":"10.1126\/science.1210214","volume":"333","author":"A Janssen","year":"2011","unstructured":"Janssen, A., van der Burg, M., Szuhai, K., Kops, G. J. & Medema, R. H. Chromosome segregation errors as a cause of DNA damage and structural chromosome aberrations. Science 333, 1895\u20131898 (2011).","journal-title":"Science"},{"key":"1242_CR62","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1038\/nature10802","volume":"482","author":"K Crasta","year":"2012","unstructured":"Crasta, K. et al. DNA breaks and chromosome pulverization from errors in mitosis. Nature 482, 53\u201358 (2012).","journal-title":"Nature"},{"key":"1242_CR63","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1038\/nature14493","volume":"522","author":"CZ Zhang","year":"2015","unstructured":"Zhang, C. Z. et al. Chromothripsis from DNA damage in micronuclei. Nature 522, 179\u2013184 (2015).","journal-title":"Nature"},{"key":"1242_CR64","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.cell.2013.06.007","volume":"154","author":"EM Hatch","year":"2013","unstructured":"Hatch, E. M., Fischer, A. H., Deerinck, T. J. & Hetzer, M. W. Catastrophic nuclear envelope collapse in cancer cell micronuclei. Cell 154, 47\u201360 (2013).","journal-title":"Cell"},{"key":"1242_CR65","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1038\/s41586-018-0534-z","volume":"561","author":"S Liu","year":"2018","unstructured":"Liu, S. et al. Nuclear envelope assembly defects link mitotic errors to chromothripsis. Nature 561, 551\u2013555 (2018).","journal-title":"Nature"},{"key":"1242_CR66","doi-asserted-by":"publisher","DOI":"10.1126\/science.adj8691","volume":"385","author":"M Di Bona","year":"2024","unstructured":"Di Bona, M. et al. Micronuclear collapse from oxidative damage. Science 385, eadj8691 (2024).","journal-title":"Science"},{"key":"1242_CR67","doi-asserted-by":"publisher","DOI":"10.1126\/science.adj7446","volume":"385","author":"S Martin","year":"2024","unstructured":"Martin, S. et al. A p62-dependent rheostat dictates micronuclei catastrophe and chromosome rearrangements. Science 385, eadj7446 (2024).","journal-title":"Science"},{"key":"1242_CR68","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.ceb.2021.01.004","volume":"70","author":"K Krupina","year":"2021","unstructured":"Krupina, K., Goginashvili, A. & Cleveland, D. W. Causes and consequences of micronuclei. Curr. Opin. Cell Biol. 70, 91\u201399 (2021).","journal-title":"Curr. Opin. Cell Biol."},{"key":"1242_CR69","doi-asserted-by":"publisher","first-page":"6055","DOI":"10.1016\/j.cell.2024.08.001","volume":"187","author":"JL Engel","year":"2024","unstructured":"Engel, J. L. et al. The Fanconi anemia pathway induces chromothripsis and ecDNA-driven cancer drug resistance. Cell 187, 6055\u20136070 (2024).","journal-title":"Cell"},{"key":"1242_CR70","doi-asserted-by":"publisher","unstructured":"Krupina, K., Goginashvili, A. & Cleveland, D. W. Scrambling the genome in cancer: causes and consequences of complex chromosome rearrangements. Nat. Rev. Genet. 25, 196\u2013210 https:\/\/doi.org\/10.1038\/s41576-023-00663-0 (2023).","DOI":"10.1038\/s41576-023-00663-0"},{"key":"1242_CR71","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1016\/j.tcb.2017.08.005","volume":"27","author":"P Ly","year":"2017","unstructured":"Ly, P. & Cleveland, D. W. Rebuilding chromosomes after catastrophe: emerging mechanisms of chromothripsis. Trends Cell Biol. 27, 917\u2013930 (2017).","journal-title":"Trends Cell Biol"},{"key":"1242_CR72","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1038\/ncb3450","volume":"19","author":"P Ly","year":"2017","unstructured":"Ly, P. et al. Selective Y centromere inactivation triggers chromosome shattering in micronuclei and repair by non-homologous end joining. Nat. Cell Biol. 19, 68\u201375 (2017).","journal-title":"Nat. Cell Biol."},{"key":"1242_CR73","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1038\/s41588-019-0576-7","volume":"52","author":"I Cortes-Ciriano","year":"2020","unstructured":"Cortes-Ciriano, I. et al. Comprehensive analysis of chromothripsis in 2,658 human cancers using whole-genome sequencing. Nat. Genet. 52, 331\u2013341 (2020).","journal-title":"Nat. Genet."},{"key":"1242_CR74","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1038\/s41586-022-04738-6","volume":"606","author":"CD Steele","year":"2022","unstructured":"Steele, C. D. et al. Signatures of copy number alterations in human cancer. Nature 606, 984\u2013991 (2022).","journal-title":"Nature"},{"key":"1242_CR75","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-16134-7","volume":"11","author":"N Voronina","year":"2020","unstructured":"Voronina, N. et al. The landscape of chromothripsis across adult cancer types. Nat. Commun. 11, 2320 (2020).","journal-title":"Nat. Commun."},{"key":"1242_CR76","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.molcel.2023.11.002","volume":"84","author":"A Mazzagatti","year":"2024","unstructured":"Mazzagatti, A., Engel, J. L. & Ly, P. Boveri and beyond: chromothripsis and genomic instability from mitotic errors. Mol. Cell 84, 55\u201369 (2024).","journal-title":"Mol. Cell"},{"key":"1242_CR77","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1182\/blood-2011-03-344069","volume":"118","author":"F Magrangeas","year":"2011","unstructured":"Magrangeas, F., Avet-Loiseau, H., Munshi, N. C. & Minvielle, S. Chromothripsis identifies a rare and aggressive entity among newly diagnosed multiple myeloma patients. Blood 118, 675\u2013678 (2011).","journal-title":"Blood"},{"key":"1242_CR78","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1038\/nature10910","volume":"483","author":"JJ Molenaar","year":"2012","unstructured":"Molenaar, J. J. et al. Sequencing of neuroblastoma identifies chromothripsis and defects in neuritogenesis genes. Nature 483, 589\u2013593 (2012).","journal-title":"Nature"},{"key":"1242_CR79","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1038\/nrc3352","volume":"12","author":"JV Forment","year":"2012","unstructured":"Forment, J. V., Kaidi, A. & Jackson, S. P. Chromothripsis and cancer: causes and consequences of chromosome shattering. Nat. Rev. Cancer 12, 663\u2013670 (2012).","journal-title":"Nat. Rev. Cancer"},{"key":"1242_CR80","doi-asserted-by":"publisher","unstructured":"Simovic-Lorenz, M. & Ernst, A. Chromothripsis in cancer. Nat. Rev. Cancer 25, 79\u201392 https:\/\/doi.org\/10.1038\/s41568-024-00769-5 (2024).","DOI":"10.1038\/s41568-024-00769-5"},{"key":"1242_CR81","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1101\/gr.6522707","volume":"17","author":"GR Bignell","year":"2007","unstructured":"Bignell, G. R. et al. Architectures of somatic genomic rearrangement in human cancer amplicons at sequence-level resolution. Genome Res. 17, 1296\u20131303 (2007).","journal-title":"Genome Res."},{"key":"1242_CR82","doi-asserted-by":"publisher","DOI":"10.1016\/j.xgen.2022.100112","volume":"2","author":"C Shale","year":"2022","unstructured":"Shale, C. et al. Unscrambling cancer genomes via integrated analysis of structural variation and copy number. Cell Genom. 2, 100112 (2022).","journal-title":"Cell Genom."},{"key":"1242_CR83","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1038\/nature09744","volume":"470","author":"MF Berger","year":"2011","unstructured":"Berger, M. F. et al. The genomic complexity of primary human prostate cancer. Nature 470, 214\u2013220 (2011).","journal-title":"Nature"},{"key":"1242_CR84","doi-asserted-by":"publisher","unstructured":"Anderson, N. D. et al. Rearrangement bursts generate canonical gene fusions in bone and soft tissue tumors. Science 361, eaam8419 https:\/\/doi.org\/10.1126\/science.aam8419 (2018).","DOI":"10.1126\/science.aam8419"},{"key":"1242_CR85","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1093\/annonc\/mdw686","volume":"28","author":"JK Lee","year":"2017","unstructured":"Lee, J. K. et al. Complex chromosomal rearrangements by single catastrophic pathogenesis in NUT midline carcinoma. Ann. Oncol. 28, 890\u2013897 (2017).","journal-title":"Ann. Oncol."},{"key":"1242_CR86","doi-asserted-by":"publisher","first-page":"1842","DOI":"10.1016\/j.cell.2019.05.013","volume":"177","author":"JJ Lee","year":"2019","unstructured":"Lee, J. J. et al. Tracing oncogene rearrangements in the mutational history of lung adenocarcinoma. Cell 177, 1842\u20131857 (2019).","journal-title":"Cell"},{"key":"1242_CR87","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s13039-019-0415-7","volume":"12","author":"F Pellestor","year":"2019","unstructured":"Pellestor, F. Chromoanagenesis: cataclysms behind complex chromosomal rearrangements. Mol. Cytogenet. 12, 6 (2019).","journal-title":"Mol. Cytogenet."},{"key":"1242_CR88","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1038\/s41580-022-00452-3","volume":"23","author":"Y Pommier","year":"2022","unstructured":"Pommier, Y., Nussenzweig, A., Takeda, S. & Austin, C. Human topoisomerases and their roles in genome stability and organization. Nat. Rev. Mol. Cell Biol. 23, 407\u2013427 (2022).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"1242_CR89","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1126\/science.aau8231","volume":"361","author":"M Imielinski","year":"2018","unstructured":"Imielinski, M. & Ladanyi, M. Fusion oncogenes\u2014genetic musical chairs. Science 361, 848\u2013849 (2018).","journal-title":"Science"},{"key":"1242_CR90","doi-asserted-by":"publisher","unstructured":"Choi, J. et al. Integrated mutational landscape analysis of uterine leiomyosarcomas. Proc. Natl Acad. Sci. USA 118, e2025182118 https:\/\/doi.org\/10.1073\/pnas.2025182118 (2021).","DOI":"10.1073\/pnas.2025182118"},{"key":"1242_CR91","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1146\/annurev-genom-120121-101149","volume":"23","author":"MR Cosenza","year":"2022","unstructured":"Cosenza, M. R., Rodriguez-Martin, B. & Korbel, J. O. Structural variation in cancer: role, prevalence, and mechanisms. Annu. Rev. Genomics Hum. Genet. 23, 123\u2013152 (2022).","journal-title":"Annu. Rev. Genomics Hum. Genet."},{"key":"1242_CR92","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1038\/ncb2897","volume":"16","author":"MK Zeman","year":"2014","unstructured":"Zeman, M. K. & Cimprich, K. A. Causes and consequences of replication stress. Nat. Cell Biol. 16, 2\u20139 (2014).","journal-title":"Nat. Cell Biol."},{"key":"1242_CR93","doi-asserted-by":"publisher","first-page":"e1000327","DOI":"10.1371\/journal.pgen.1000327","volume":"5","author":"PJ Hastings","year":"2009","unstructured":"Hastings, P. J., Ira, G. & Lupski, J. R. A microhomology-mediated break-induced replication model for the origin of human copy number variation. PLoS Genet. 5, e1000327 (2009).","journal-title":"PLoS Genet."},{"key":"1242_CR94","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1126\/science.1243211","volume":"343","author":"L Costantino","year":"2014","unstructured":"Costantino, L. et al. Break-induced replication repair of damaged forks induces genomic duplications in human cells. Science 343, 88\u201391 (2014).","journal-title":"Science"},{"key":"1242_CR95","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1038\/nature24477","volume":"551","author":"NA Willis","year":"2017","unstructured":"Willis, N. A. et al. Mechanism of tandem duplication formation in BRCA1-mutant cells. Nature 551, 590\u2013595 (2017).","journal-title":"Nature"},{"key":"1242_CR96","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1016\/j.cell.2013.01.006","volume":"152","author":"JH Barlow","year":"2013","unstructured":"Barlow, J. H. et al. Identification of early replicating fragile sites that contribute to genome instability. Cell 152, 620\u2013632 (2013).","journal-title":"Cell"},{"key":"1242_CR97","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1016\/j.cell.2018.03.072","volume":"173","author":"L Vian","year":"2018","unstructured":"Vian, L. et al. The energetics and physiological impact of cohesin extrusion. Cell 173, 1165\u20131178 (2018).","journal-title":"Cell"},{"key":"1242_CR98","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-28237-4","volume":"13","author":"AC Katz-Summercorn","year":"2022","unstructured":"Katz-Summercorn, A. C. et al. Multi-omic cross-sectional cohort study of pre-malignant Barrett\u2019s esophagus reveals early structural variation and retrotransposon activity. Nat. Commun. 13, 1407 (2022).","journal-title":"Nat. Commun."},{"key":"1242_CR99","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1038\/s41586-023-06102-8","volume":"618","author":"K Karlsson","year":"2023","unstructured":"Karlsson, K. et al. Deterministic evolution and stringent selection during preneoplasia. Nature 618, 383\u2013393 (2023).","journal-title":"Nature"},{"key":"1242_CR100","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2021.804547","volume":"12","author":"W Wu","year":"2021","unstructured":"Wu, W., He, J. N., Lan, M., Zhang, P. & Chu, W. K. Transcription\u2013replication collisions and chromosome fragility. Front. Genet. 12, 804547 (2021).","journal-title":"Front. Genet."},{"key":"1242_CR101","doi-asserted-by":"publisher","first-page":"1488","DOI":"10.1038\/s41587-022-01289-z","volume":"40","author":"AS Deshpande","year":"2022","unstructured":"Deshpande, A. S. et al. Identifying synergistic high-order 3D chromatin conformations from genome-scale nanopore concatemer sequencing. Nat. Biotechnol. 40, 1488\u20131499 (2022).","journal-title":"Nat. Biotechnol."},{"key":"1242_CR102","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-29767-7","volume":"13","author":"TG Paulson","year":"2022","unstructured":"Paulson, T. G. et al. Somatic whole genome dynamics of precancer in Barrett\u2019s esophagus reveals features associated with disease progression. Nat. Commun. 13, 2300 (2022).","journal-title":"Nat. Commun."},{"key":"1242_CR103","doi-asserted-by":"publisher","first-page":"3796","DOI":"10.1158\/0008-5472.CAN-23-0385","volume":"83","author":"MD Kinnaman","year":"2023","unstructured":"Kinnaman, M. D. et al. Subclonal somatic copy-number alterations emerge and dominate in recurrent osteosarcoma. Cancer Res. 83, 3796\u20133812 (2023).","journal-title":"Cancer Res."},{"key":"1242_CR104","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1038\/nbt.4192","volume":"36","author":"M Kosicki","year":"2018","unstructured":"Kosicki, M., Tomberg, K. & Bradley, A. Repair of double-strand breaks induced by CRISPR\u2013Cas9 leads to large deletions and complex rearrangements. Nat. Biotechnol. 36, 765\u2013771 (2018).","journal-title":"Nat. Biotechnol."},{"key":"1242_CR105","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1038\/nrg906","volume":"3","author":"H Youssoufian","year":"2002","unstructured":"Youssoufian, H. & Pyeritz, R. E. Mechanisms and consequences of somatic mosaicism in humans. Nat. Rev. Genet. 3, 748\u2013758 (2002).","journal-title":"Nat. Rev. Genet."},{"key":"1242_CR106","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1038\/s41588-018-0071-6","volume":"50","author":"JM Goldmann","year":"2018","unstructured":"Goldmann, J. M. et al. Germline de novo mutation clusters arise during oocyte aging in genomic regions with high double-strand-break incidence. Nat. Genet. 50, 487\u2013492 (2018).","journal-title":"Nat. Genet."},{"key":"1242_CR107","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/j.tips.2022.02.007","volume":"43","author":"MJ Grillo","year":"2022","unstructured":"Grillo, M. J., Jones, K. F. M., Carpenter, M. A., Harris, R. S. & Harki, D. A. The current toolbox for APOBEC drug discovery. Trends Pharmacol. Sci. 43, 362\u2013377 (2022).","journal-title":"Trends Pharmacol. Sci."}],"container-title":["Nature Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s43018-026-01242-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s43018-026-01242-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s43018-026-01242-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T14:01:54Z","timestamp":1792764114000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s43018-026-01242-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,25]]},"references-count":107,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2026,10]]}},"alternative-id":["1242"],"URL":"https:\/\/doi.org\/10.1038\/s43018-026-01242-y","relation":{},"ISSN":["2662-1347"],"issn-type":[{"value":"2662-1347","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,25]]},"assertion":[{"value":"8 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"L.B.A. is a cofounder, chief scientific officer, scientific advisory member and consultant for Acurion (formerly io9), has equity and receives income. The terms of this arrangement have been reviewed and approved by the University of California, San Diego, in accordance with its conflict of interest policies. L.B.A. is a compensated member of the scientific advisory board of Inocras, and he reports receiving honoraria for scientific presentations, including from Pfizer. L.B.A.\u2019s spouse is an employee of Hologic. L.B.A. declares US provisional applications with serial numbers 63\/289,601; 63\/269,033; 63\/366,392; 63\/412,835 and 63\/966,993, as well as international patent application PCT\/US2023\/010679. L.B.A. is also an inventor of US patent 10,776,718 for source identification by non-negative matrix factorization. L.B.A. further declares a European patent application with application number EP25305077.7. All other authors declare that they have no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}]}}